Dr Lal Pathlabs Ltd.
|BSE: 539524||Sector: Health care|
|NSE: LALPATHLAB||ISIN Code: INE600L01024|
|BSE 15:10 | 01 Dec||2285.75||
|NSE 14:59 | 01 Dec||2284.25||
|Mkt Cap.(Rs cr)||19,049|
|Mkt Cap.(Rs cr)||19049.44|
Dr Lal Pathlabs Ltd. (LALPATHLAB) - Latest News & Headlines
11.51 am | 24 Nov 2020 | Business Standard
Thyrocare Technologies has the strong support of 50-DMA, currently placed at Rs 988 levels.
11.43 am | 10 Nov 2020 | Business Standard
From March lows, the stock price of Thyrocare Technologies has been more-than-tripled and of Dr Lal PathLabs more-than-doubled on the BSE
2.10 pm | 7 Oct 2020 | Business Standard
A new all time high shows bullish sentiment is here to stay in these stocks.
11.13 am | 7 Oct 2020 | Business Standard
Thyrocare Technologies, Metropolis Healthcare and Dr. Lal PathLabs, hitting their respective record highs, were up 9 per cent to 17 per cent on the BS...
8.24 am | 16 Sep 2020 | Business Standard
All indicators point to a gradual rise in Aurobindo Pharma's stock from the 100 EMA support
5.32 pm | 4 Aug 2020 | Business Standard
Valuations too do not leave much scope for gains
12.06 pm | 15 Jul 2020 | Business Standard
Reliance Industries, Larsen & Toubro Infotech and Dr Lal Pathlabs from S&P BSE500 index hit record highs today.
1.27 pm | 13 Jul 2020 | Business Standard
Metropolis Healthcare, meanwhile, rallied 7% to Rs 1,579 today, and were trading higher for the eighth straight day
11.38 am | 24 Jun 2020 | Business Standard
Stocks of diagnostic chains and hospitals have been in focus as Covid-19 pandemic spread across the country. Is it a good strategy to stay put in thes...